May 17, 2010
In a New York Times article today, Intel founder Andrew Grove talks about his gift to UC Berkeley/UCSF for the new joint Master’s Degree program in Bioengineering.
The degree program, offered through the existing Joint Graduate Group in Bioengineering at Berkeley/UCSF, will focus on translational medicine: quickly bringing scientific research ‘from bench to bedside’.
Read the full article in the New York Times, or check out the press release on the masters program at UC Berkeley News Center.